FDA Faster Approval Times For 2002 NMEs Aided By Resubmissions
Executive Summary
The average total approval time for new molecular entities cleared by FDA in 2002 was 15.2 months, an analysis of new drug approvals shows
You may also be interested in...
GSK R&D Initiative Sees Early Success: Phase II NCEs Up Three-Fold
GlaxoSmithKline's R&D productivity program has experienced some early successes in the number of compounds coming out of the early-stage pipeline
GSK R&D Initiative Sees Early Success: Phase II NCEs Up Three-Fold
GlaxoSmithKline's R&D productivity program has experienced some early successes in the number of compounds coming out of the early-stage pipeline
FDA 2002 NME approval times (correction)
FDA's average approval time for new molecular entities approved in 2002 is 17 months. "The Pink Sheet" (1Jan. 6, p. 10) incorrectly reported that Alliance Pharmaceuticals' Imagent NDA had been resubmitted and therefore miscalculated the approval time average. Imagent (perflexane) was approved in 31.6 months...